RA Trademark

Trademark Overview

On Monday, October 19, 2020, a trademark application was filed for RA with the United States Patent and Trademark Office. The USPTO has given the RA trademark a serial number of 90263893. The federal status of this trademark filing is REGISTERED as of Tuesday, May 7, 2024. This trademark is owned by Revance Therapeutics, Inc.. The RA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of wrinkles; Dermatological pharmaceutical products and pharmaceutical preparations injected into or under the skin, into or under mucous membranes for filling in wrinkles, skin depressions for remodeling, increasing volume in the face, for moisturizing the skin or mucous membranes, for increasing lip volume; none of the foregoing are for prevention or treatment of rheumatoid arthritis
ra

General Information

Serial Number90263893
Word MarkRA
Filing DateMonday, October 19, 2020
Status700 - REGISTERED
Status DateTuesday, May 7, 2024
Registration Number7381054
Registration DateTuesday, May 7, 2024
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 17, 2021

Trademark Statements

Description of MarkThe mark consists of the stylized letters "RA".
Goods and ServicesPharmaceutical preparations for the treatment of wrinkles; Dermatological pharmaceutical products and pharmaceutical preparations injected into or under the skin, into or under mucous membranes for filling in wrinkles, skin depressions for remodeling, increasing volume in the face, for moisturizing the skin or mucous membranes, for increasing lip volume; none of the foregoing are for prevention or treatment of rheumatoid arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2020
Primary Code005
First Use Anywhere DateSunday, December 31, 2023
First Use In Commerce DateSunday, December 31, 2023

Trademark Owner History

Party NameRevance Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGLENGORMLEY BT365EB
GB
Party NameRevance Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, CA 94560
Party NameRevance Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events

Event DateEvent Description
Thursday, October 22, 2020NEW APPLICATION ENTERED
Tuesday, December 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 7, 2021ASSIGNED TO EXAMINER
Tuesday, January 12, 2021NON-FINAL ACTION WRITTEN
Tuesday, January 12, 2021NON-FINAL ACTION E-MAILED
Tuesday, January 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 14, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 17, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 17, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 4, 2022SOU TEAS EXTENSION RECEIVED
Monday, April 4, 2022SOU EXTENSION 1 FILED
Monday, April 4, 2022SOU EXTENSION 1 GRANTED
Wednesday, April 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 11, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 11, 2022SOU EXTENSION 2 FILED
Tuesday, October 11, 2022SOU EXTENSION 2 GRANTED
Thursday, October 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 12, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 12, 2023SOU EXTENSION 3 FILED
Wednesday, April 12, 2023SOU EXTENSION 3 GRANTED
Friday, April 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU EXTENSION 4 FILED
Tuesday, October 10, 2023SOU EXTENSION 4 GRANTED
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 14, 2024USE AMENDMENT FILED
Wednesday, February 14, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, March 5, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 5, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, April 1, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 2, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 7, 2024REGISTERED-PRINCIPAL REGISTER
Monday, August 4, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 4, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 4, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 4, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 7, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

pharmaceutical skin mucous membranes increasing volume under preparations treatment wrinkles